Related Experiment Videos
[Acute phase reaction in acute viral hepatitis]
1Abteilung für Kinderinfektionskrankheiten und interne Kinderkrankheiten, Universität Wien.
Padiatrie Und Padologie
|January 1, 1990
Summary
Acute viral hepatitis shows minimal changes in acute-phase proteins and complement levels, suggesting no systemic acute phase response despite liver inflammation. This finding holds true across different hepatitis types and patient demographics.
Area of Science:
- Hepatology
- Immunology
- Clinical Biochemistry
Context:
- Acute viral hepatitis, including hepatitis A and B, involves significant liver inflammation.
- The body's acute phase response is a complex systemic reaction to inflammation or infection.
- Serum biomarkers like acute-phase proteins and complement components are often monitored in inflammatory conditions.
Purpose:
- To investigate serum concentrations of specific acute-phase proteins (alpha 1-antitrypsin, alpha 1-acid glycoprotein, C-reactive protein) and complement components (C3, C4).
- To correlate these biochemical markers with the clinical course of acute hepatitis A and hepatitis B.
- To assess the presence and extent of a systemic acute phase response in viral hepatitis, considering patient age and sex.
Summary:
- Serum levels of alpha 1-antitrypsin, alpha 1-acid glycoprotein, and C-reactive protein showed only minor increases during acute hepatitis A.
- Hepatitis B was associated with elevated alpha 1-antitrypsin and C-reactive protein, but not alpha 1-acid glycoprotein.
- Moderate elevations in complement components C3 and C4 were observed in both hepatitis A and B, with a more pronounced effect in hepatitis B, followed by a gradual normalization.
Impact:
- The study suggests that acute viral hepatitis, despite significant liver inflammation, does not elicit a pronounced systemic acute phase response.
- Findings indicate differential patterns of acute-phase protein and complement activation between hepatitis A and B.
- This research contributes to understanding the immunobiology of viral hepatitis and the limitations of systemic inflammatory markers in this context.